Ramkumar N, et al. - Using the Medicare-linked Vascular Quality Initiative registry, researchers examined patients with peripheral arterial disease who underwent endovascular interventions from 2010 to 2015, to analyze 5-year clinical outcomes by endovascular treatment type [atherectomy (with or without percutaneous transluminal angioplasty [PTA]), stent (with or without PTA), or PTA alone] in these subjects. Overall eligible patients were 16,838, with median follow-up of 1.3–1.5 years; of these, atherectomy, PTA alone, and stenting were received by 11%, 40%, and 49%, respectively. Femoropopliteal artery treatment was common among patients receiving atherectomy; these patients had worse disease severity. Findings revealed the use of atherectomy as a treatment modality for severe femoropopliteal and tibial peripheral arterial disease, despite more frequent occurrence of long-term adverse outcomes after this procedure.